Cannara Biotech Inc. (TSXV:LOVE)

Cannara Biotech Balance Sheet

Financials in millions CAD. Fiscal year is September - August.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 30, 2024	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Cash & Equivalents	10.26	6.62	4.27	12.11	8.16	7.77
Cash & Short-Term Investments	10.26	6.62	4.27	12.11	8.16	7.77
Cash Growth	288.77%	55.03%	-64.75%	48.48%	4.99%	-70.68%
Accounts Receivable	12.93	13.04	10.59	8.62	2.92	0.06
Other Receivables	-	-	-	-	0.05	0.25
Receivables	12.93	13.04	10.59	8.62	2.97	0.31
Inventory	41.74	40.07	33.77	18.98	7.41	2.24
Prepaid Expenses	3.41	2.85	3.06	1.28	0.71	0.21
Other Current Assets	4.9	4.9	-	-	-	-
Total Current Assets	73.25	67.47	51.7	40.99	19.25	10.53
Property, Plant & Equipment	85.88	84.94	89.44	83.4	71.75	43.64
Other Intangible Assets	-	-	-	-	-	0.16
Long-Term Accounts Receivable	-	-	-	-	0.07	0.07
Long-Term Deferred Tax Assets	1.23	1.95	-	-	-	-
Long-Term Deferred Charges	-	-	0.06	-	-	-
Other Long-Term Assets	0.65	0.36	0.33	1.22	0.95	0.44
Total Assets	161	154.72	141.52	125.62	92.02	54.85
Accounts Payable	11.52	9.5	8.12	8.85	6.19	2.76
Accrued Expenses	8.59	7.86	6.86	0.77	0.07	0.16
Short-Term Debt	6.76	6.26	3	-	-	-
Current Portion of Long-Term Debt	8.91	2.97	2.97	1.97	0.3	0.3
Current Portion of Leases	0.3	0.28	0.08	0.22	0.23	0.21
Current Unearned Revenue	0.43	0.13	0.16	0.05	0.04	0.05
Total Current Liabilities	36.5	27	21.18	11.86	6.83	3.48
Long-Term Debt	32.68	38.45	39.64	46.19	20.15	11.98
Long-Term Leases	0.33	0.37	0.1	0.02	0.22	0.44
Long-Term Unearned Revenue	0.92	0.94	0.86	0.82	0.71	0.51
Other Long-Term Liabilities	-	-	-	-	-	0.08
Total Liabilities	70.43	66.77	61.78	58.88	27.91	16.49
Common Stock	88.52	88.52	88.8	83.3	83.21	58.36
Additional Paid-In Capital	12.65	12.33	10.35	9.72	9.41	7.03
Retained Earnings	-10.59	-12.9	-19.34	-26.3	-28.61	-27.08
Comprehensive Income & Other	-	-	-0.07	0.02	0.1	0.05
Total Common Equity	90.58	87.95	79.74	66.74	64.12	38.36
Shareholders' Equity	90.58	87.95	79.74	66.74	64.12	38.36
Total Liabilities & Equity	161	154.72	141.52	125.62	92.02	54.85
Total Debt	48.97	48.33	45.78	48.39	20.9	12.94
Net Cash (Debt)	-38.71	-41.71	-41.51	-36.28	-12.74	-5.16
Net Cash Per Share	-0.42	-0.46	-0.46	-0.41	-0.17	-0.07
Filing Date Shares Outstanding	90.64	90.02	90.02	87.7	87.65	73.78
Total Common Shares Outstanding	90.02	90.02	90.31	87.7	87.65	73.77
Working Capital	36.74	40.47	30.51	29.13	12.41	7.05
Book Value Per Share	1.01	0.98	0.88	0.76	0.73	0.52
Tangible Book Value	90.58	87.95	79.74	66.74	64.12	38.2
Tangible Book Value Per Share	1.01	0.98	0.88	0.76	0.73	0.52
Land	2.33	2.33	2.45	2.45	2.45	1.1
Buildings	77.29	76.71	75.48	64.3	44.79	37.63
Machinery	22.36	20.65	18.57	14.22	8.47	7.2
Construction In Progress	4.86	4.71	6.73	11.53	21.23	-

Source: S&P Capital IQ. Standard template. Financial Sources.